Seritage Growth Stock Analysis: Buy or Sell? Liquidity, Cash Burn & Valuation

Quick Thesis

• Rated strong sell — the Plan of Sale is still execution-risk heavy.
• Liquidity is the main cushion: current ratio is 6.2x and cash is $48.4M.
• The core risk is cash burn: levered free cash flow is $-23.3M TTM.
• Valuation is not cheap on sales: EV/Revenue is 9.7x despite negative EBITDA.
• I would turn more constructive only if operating cash flow turns positive and asset sales accelerate.

Executive Summary

Rating: STRONG SELL | SRG

I would put my rating as a strong sell because Seritage Growth Properties is still a liquidation case with no operating earnings base, and the market is paying a sales multiple for a portfolio that has not yet converted asset sales into durable equity value. TTM EBITDA margin was -154.9% and levered free cash flow margin was -186.2%, so the business is still consuming cash rather than funding itself. The key risk is execution on the Plan of Sale: the company has only $11M of property under contract as of March 31, 2026, while the Term Loan Facility matures on July 31, 2026, which leaves little room for delay. I would raise my rating only if asset sales accelerate enough to push operating cash flow into positive territory, meaning the portfolio is funding itself instead of shrinking.

Company Profile

Seritage Growth Properties is a real estate investment trust focused on owning, managing, and monetizing a portfolio of retail and mixed-use properties. The company’s current model is not growth through development; it is asset disposition, with proceeds intended to support debt repayment and, if possible, distributions to shareholders. That makes the business highly sensitive to transaction timing, buyer demand, and financing conditions.

Economic Moat

Business Model

The company’s structural advantage, if it has one, is the optionality embedded in its real estate portfolio. Seritage can sell assets individually rather than as a forced portfolio, which can preserve value if the market is receptive and if management can sequence transactions well. I view that as a narrow advantage, not a durable moat: it depends more on execution and market conditions than on a hard-to-copy operating franchise.

Business & Operating Risks

The most material disclosed risk is execution failure on the Plan of Sale, because the filing says there is no assurance the company can complete strategic transactions on terms satisfactory to the Board of Trustees and that distributions may be delayed or reduced if buyers do not show up at the right price. Financing risk is also explicit: the company has not yet reached the $200M annualized non-Sears Holdings tenant rental income needed to access the $400M incremental facility, so the backup liquidity source remains out of reach. Control and legal risks add pressure, including material weaknesses in internal control over financial reporting and litigation tied to a ground lease dispute. Taken together, these risks do not threaten a strong operating moat so much as they expose the absence of one; the business is being wound down, not defended.

Management Discussion & Analysis

Management is clearly trying to address the risks through asset sales and debt reduction, but it has not yet solved the timing problem. In 2025, Seritage sold five wholly owned assets for $222.6 million of gross proceeds and monetized two unconsolidated properties for another $8.1 million, while also repaying $190.0 million of Term Loan Facility principal. That is real progress, yet the company still needed a maturity extension to July 31, 2026 and still had negative operating cash flow, so the sale program is reducing risk without eliminating it.

Recent Events

The June 1, 2026 option purchase and sale agreement for the Dallas property, with a $50.8M purchase price and a closing window that can extend to January 31, 2028, shows the monetization process is still alive. I read that as supportive of the thesis, but not as a near-term fix, because the long closing window means value realization may still be slow. The repeated preferred dividend declarations on February 25, 2026 and April 20, 2026 also show the capital structure is still being serviced, which helps the preferred layer more than the common equity.

Financial Analysis

Growth

SRG — Financial Growth (Quarterly, USD Mil)

Source: Yahoo Finance — Quarterly Financial Statements

Revenue fell from $4.8M in Q3 2025 to $4.2M in Q4 2025 and then to $2.1M in Q1 2026, so the latest quarter was a sharp step down rather than a smooth drift. Q1 2026 revenue was down 55.4% from $4.6M in Q1 2025, while EBITDA moved from $-15M to $-27M over the same span and net income from $-22.2M to $-30.3M. That is consistent with a liquidation process that is still shrinking the operating base faster than it is stabilizing it.

Profitability

SRG — Profitability (TTM)

Source: Yahoo Finance — Trailing Twelve Months (TTM)

TTM operating margin of -178.4% and EBITDA margin of -154.9% show the portfolio is still consuming far more overhead than it can absorb from property-level income. Gross margin was 7.4%, which means the issue is not only corporate overhead; the assets themselves are barely covering direct costs. ROA of -3.0% and ROE of -16.7% confirm that capital is still being destroyed, not compounded, and the gap between the two suggests leverage is amplifying weak asset returns rather than creating equity value.

Valuation

SRG — Valuation Multiples

Source: Yahoo Finance

Seritage trades at 9.7x EV/Revenue and 9.6x Price/Sales, with EV/EBITDA at -6.3x because EBITDA is still negative. That is not a cheapness signal in my view; it says the market is paying for a successful asset-sale outcome rather than for operating earnings. Book value per share is $5.19 versus an implied share price of about $2.1, so the stock still trades at a steep discount to reported equity, but that discount reflects the cash-burn profile and the execution risk around monetization.

On the analysis here, I would put fair value in a range of about $1.1-$3.7 per share based on peer EV/Revenue, with the lower end more relevant because SRG’s revenue is falling while peers are growing. That range sits around or slightly below the current share area, so I do not see a clear valuation gap that would justify a more bullish call. There is no meaningful analyst consensus to compare against because the reference data shows no target prices and no coverage count.

Forward EPS is $2.2, which looks rich relative to the stock’s cash generation because the company is still posting negative FCF yield. I would treat that EPS figure cautiously: it is not yet backed by the kind of margin profile that would make it comparable to peers on a quality basis. In other words, the headline earnings multiple is less important here than whether the sale process can turn those earnings into cash.

Leverage

SRG — Leverage & Coverage (Quarterly)

Source: Yahoo Finance — Quarterly Financial Statements

Seritage’s balance sheet is not stretched on paper. Total debt/equity was 17.2%, current ratio was 6.2x, and total debt was $50.3M, so near-term liquidity looks adequate. The problem is cash conversion: operating cash flow was $-21M, levered free cash flow was $-23.3M, and FCF margin was -186.2%, which means the company is still funding losses rather than compounding capital. The $48.4M cash balance gives time, but not a self-funding model.

Insider Activity

The insider transaction record I see here is one-sided: 8 open-market sales and 0 open-market purchases over 2025-03-15 to 2026-03-31. All of the activity came from Yakira Capital Management, Inc., a 10%+ owner, so this is really beneficial-owner selling rather than broad insider participation. I view that as a negative signal because the available record shows selling only, not conviction buying.

Comparable Analysis

Growth

Source: Yahoo Finance

SRG’s revenue fell 56.0% TTM, while TRNO grew 11.1%, SPG 19.5%, CTO 16.5%, BFS 8.4%, and GTY 5.4%. EBITDA was $-19.4M for SRG versus $304.1M at TRNO and $5.1B at SPG, so SRG is not just lagging peers but moving in the opposite direction. That gap matters because the market is not paying SRG a growth premium; it is paying for a turnaround in asset monetization that still has to show up.

Valuation

Source: Yahoo Finance

SRG trades at 9.7x EV/Revenue and 9.6x Price/Sales, versus TRNO at 16.6x and 14.8x, SPG at 14.5x and 11.9x, CTO at 9.1x and 5.1x, BFS at 9.2x and 3.9x, and GTY at 11.0x and 8.8x. The more telling comparison is FCF yield: SRG is at -19.4%, while TRNO is 4.3%, SPG 3.1%, CTO 4.5%, BFS 7.2%, and GTY 5.3%, so SRG is burning cash while peers are generating it. That is why I do not think the stock is cheap on a growth-adjusted basis, even though the headline multiple is below some peers.

Profitability

Source: Yahoo Finance

SRG’s gross margin is 7.4%, EBITDA margin is -154.9%, operating margin is -178.4%, and net margin is 0.0%, while TRNO posts 76.2%, 60.5%, 41.8%, and 77.3%; SPG shows 81.4%, 73.8%, 46.0%, and 66.6%; CTO 74.6%, 61.5%, 25.4%, and 32.6%; BFS 70.3%, 59.7%, 41.1%, and 11.5%; and GTY 96.4%, 90.5%, 47.1%, and 42.7%. The gross-margin gap is already severe, and the wider operating and EBITDA gaps say the problem is both direct property economics and overhead. In my view, that makes SRG look fundamentally different from the peer set: the others are operating real estate platforms, while SRG is still in wind-down mode.

Leverage

Source: Yahoo Finance

SRG’s debt/equity is 17.2%, current ratio is 6.2x, net debt/EBITDA is -0.1x, and FCF margin is -186.2%. TRNO is at 21.4%, 0.6x, 3.0x, and 63.5%; SPG at 503.5%, 0.3x, 5.5x, and 37.4%; CTO at 99.4%, 3.0x, 6.5x, and 22.7%; BFS at 341.8%, 0.6x, 8.8x, and 28.0%; and GTY at 81.1%, 1.7x, 2.5x, and 46.6%. SRG’s low net debt is a cushion, but the negative FCF margin means that cushion is being used to fund losses rather than create equity value. That is why the balance sheet helps survival more than it helps valuation.

Conclusion

I would put my rating as a strong sell because the central tension is not whether Seritage has assets to sell, but whether those assets can be monetized fast enough to outrun the cash burn and the July 31, 2026 debt maturity. The company does have a liquidity cushion, and the sale program is real, but the numbers still show a business with negative operating margin, negative free cash flow, and no evidence yet that the liquidation process is creating durable equity value.

I would move this rating more toward a sell if the company keeps closing assets at the current pace and operating cash flow turns positive for two consecutive quarters, because that would mean monetization is finally outrunning the burn. The key threshold is positive operating cash flow, which would show the portfolio is starting to fund itself rather than shrinking into the balance sheet. I would also watch the next property closings against the $11M contract already disclosed for the March 31, 2026 asset; if those proceeds come in materially below that level, it would suggest the sale process is weakening rather than improving.

The bear case is more likely if the July 31, 2026 maturity approaches without a completed sale package that covers it, or if revenue keeps sliding from the $2.1M reported in Q1 2026. In that scenario, the going concern pressure would intensify and more value would migrate toward lenders instead of common shareholders. I lean to that outcome because the company still has negative cash generation, and the recent asset sales, while real, are not yet enough to offset the operating losses.

What to Watch Next

• Operating cash flow turns positive — would support moving the rating toward sell.
• Asset sales close at or above the $11M contract value — would support the monetization thesis.
• The July 31, 2026 debt maturity is addressed — would reduce near-term going-concern pressure.
• Revenue stabilizes above $2.1M per quarter — would suggest the cash base is no longer deteriorating.
• FCF margin improves from -186.2% — would show the business is moving toward self-funding.

What’s your take? I rated Seritage Growth (SRG) STRONG SELL above — but the goal here is to get this right, not just to publish an opinion. What would you add to this analysis, or which risk or catalyst do you think I’m under- or over-weighting? Tell me in the comments.

Sources

• SEC 10-K Annual Report — filed 2026-03-31
• SEC 8-K Filing (2026-06-01)
• SEC 8-K Filing (2026-05-15)
• SEC 8-K Filing (2026-04-20)
• SEC 8-K Filing (2026-03-31)
• SEC 8-K Filing (2026-02-25)
• SEC Form 4 Insider Transaction (2026-04-01)
• SEC Form 4 Insider Transaction (2026-02-24)
• SEC Form 4 Insider Transaction (2026-02-09)
• SEC 10-K Annual Report — FY2026
• SEC 10-K Annual Report — FY2025
• SEC 10-K Annual Report — FY2024
• SEC 10-K Annual Report — FY2023
• SEC 10-K Annual Report — FY2022

Data sourced from Yahoo Finance and SEC EDGAR. Not investment advice.